- Home
- LIPO
as 12-18-2024 1:39pm EST
Lipella Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is focused on developing new drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for new applications. The company's product candidates include LP-10, LP-310 and LP-410 which can be helpful in treatment of Hemorrahagic Cystitis, Oral Licen Planus and Oral Graft.
| Founded: | 2005 | Country: | United States |
| Employees: | N/A | City: | PITTSBURGH |
| Market Cap: | 3.5M | IPO Year: | 2022 |
| Target Price: | $16.00 | AVG Volume (30 days): | 170.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -4.46 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.21 - $12.00 | Next Earning Date: | 11-14-2024 |
| Revenue: | $483,533 | Revenue Growth: | 0.78% |
| Revenue Growth (this year): | -17.65% | Revenue Growth (next year): | N/A |
Latest Lipella Pharmaceuticals Inc. News
LIPO Breaking Stock News: Dive into LIPO Ticker-Specific Updates for Smart Investing
GlobeNewswire
15 days ago
Lipella Pharmaceuticals Announces Publication in CUREUS on Non-Steroid Treatment of Oral Lichen Planus
GlobeNewswire
a month ago
Lipella Pharmaceuticals Announces Completion of First Cohort in Phase 2a Trial of LP-310 for Oral Lichen Planus, Advancing to Next Dose Group
Simply Wall St.
a month ago
Lipella Pharmaceuticals Third Quarter 2024 Earnings: US$1.29 loss per share (vs US$1.84 loss in 3Q 2023)
GlobeNewswire
a month ago
Lipella Pharmaceuticals Secures Extended Market Exclusivity with Issuance of U.S. Patent for Liposomal Delivery Platform
MT Newswires
2 months ago
Lipella Pharmaceuticals Launching 1-for-8 Reverse Stock Split
GlobeNewswire
2 months ago
Lipella Pharmaceuticals Announces 1-for-8 Reverse Stock Split
GlobeNewswire
2 months ago
Lipella Pharmaceuticals to Present at 2024 Spartan Capital Investor Conference
GlobeNewswire
2 months ago
Lipella Pharmaceuticals Announces U.S. Patent Allowance for Innovative Liposomal Drug Delivery Platform
Compare LIPO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "LIPO Lipella Pharmaceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.